APA-viite

Young, L. R., Franz, D. N., Nagarkatte, P., Fletcher, C. D. M., Wikenheiser-Brokamp, K. A., Galsky, M. D., . . . McCormack, F. X. (2009). Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians.

Chicago-tyylinen lähdeviittaus

Young, Lisa R., et al. Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians, 2009.

MLA-viite

Young, Lisa R., et al. Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians, 2009.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.